Expression and Function of Somatostatin Receptor Subtype 1 in Human Growth Hormone Secreting Pituitary Tumors Deriving from Patients Partially Responsive or Resistant to Long-Term Treatment with Somatostatin Analogs

Publisher： Karger

E-ISSN： 1423-0194|79|3|142-148

ISSN： 0028-3835

Source： Neuroendocrinology, Vol.79, Iss.3, 2004-05, pp. : 142-148

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Somatostatin Receptor Expression in GH-Secreting Pituitary Adenomas Treated with Long-Acting Somatostatin Analogues in Combination with Pegvisomant

By  

Neuroendocrinology, Vol. 105, Iss. 1, 2016-07 ,pp. : 44-53

Karger

Access to resources Recommend Favorite

Differential Inhibition of Growth Hormone Secretion by Analogs Selective for Somatostatin Receptor Subtypes 2 and 5 in Human Growth-Hormone-Secreting Adenoma Cells in vitro

By  

Neuroendocrinology, Vol. 73, Iss. 5, 2001-05 ,pp. : 344-351

Karger

Access to resources Recommend Favorite

Long-Term Inhibitory Effects of Somatostatin and Insulin-Like Growth Factor 1 on Growth Hormone Release by Serum-Free Primary Culture of Pituitary Cells from European Eel (Anguilla anguilla)

By  

Neuroendocrinology, Vol. 67, Iss. 4, 1998-05 ,pp. : 301-309

Karger

Access to resources Recommend Favorite

Role of Glucocorticoids in the Regulation of Pituitary Somatostatin Receptor Subtype (sst1–sst5) mRNA Levels: Evidence for Direct and Somatostatin-Mediated Effects

By  

Neuroendocrinology, Vol. 78, Iss. 3, 2003-10 ,pp. : 163-175

Karger

Access to resources Recommend Favorite

Hypothalamic Somatostatin and Growth Hormone-Releasing Hormone mRNA Expression Depend upon GABAA Receptor Expression in the Developing Mouse

By  

Neuroendocrinology, Vol. 76, Iss. 2, 2002-08 ,pp. : 93-98

Karger

Access to resources Recommend Favorite